108 related articles for article (PubMed ID: 30243897)
1. Expression of epidermal growth factor receptor (EGFR) in colorectal cancer: An immunohistochemical study.
Ben Brahim E; Ayari I; Jouini R; Atafi S; Koubaa W; Elloumi H; Chadli A
Arab J Gastroenterol; 2018 Sep; 19(3):121-124. PubMed ID: 30243897
[TBL] [Abstract][Full Text] [Related]
2. Epidermal Growth Factor Receptor Expression of Colorectal Carcinoma in Nigerian Patients.
Lawan AI; Ogunbiyi JO
West Afr J Med; 2020; 37(2):100-105. PubMed ID: 32150626
[TBL] [Abstract][Full Text] [Related]
3. Increased epidermal growth factor receptor expression at the invasive margin is a negative prognostic factor in colorectal cancer.
Ljuslinder I; Melin B; Henriksson ML; Öberg Å; Palmqvist R
Int J Cancer; 2011 May; 128(9):2031-7. PubMed ID: 20635387
[TBL] [Abstract][Full Text] [Related]
4. Expression of membranous epidermal growth factor receptor in colorectal adenocarcinoma and its correlation with clinicopathological features.
Mohammadi G; Jamialahmadi K; Lary S; Ghaffarzadegan K
Pak J Biol Sci; 2011 Mar; 14(5):357-62. PubMed ID: 21874828
[TBL] [Abstract][Full Text] [Related]
5. Expression of EGFR, Her2 predict lymph node metastasis (LNM)-associated metastasis in colorectal cancer.
Lu Y; Jingyan G; Baorong S; Peng J; Xu Y; Cai S
Cancer Biomark; 2012; 11(5):219-26. PubMed ID: 23220854
[TBL] [Abstract][Full Text] [Related]
6. Discordance between EGFR expression and clinicopathologic parameters of colorectal adenocarcinoma in Taiwan.
Tsai WC; Lin CK; Lee HS; Chen A; Nieh S; Yu CP; Wu CC; Jao SW; Jin JS
Chin J Physiol; 2012 Oct; 55(5):352-60. PubMed ID: 23282210
[TBL] [Abstract][Full Text] [Related]
7. FAK, CD44v6, c-Met and EGFR in colorectal cancer parameters: tumour progression, metastasis, patient survival and receptor crosstalk.
Garouniatis A; Zizi-Sermpetzoglou A; Rizos S; Kostakis A; Nikiteas N; Papavassiliou AG
Int J Colorectal Dis; 2013 Jan; 28(1):9-18. PubMed ID: 22733437
[TBL] [Abstract][Full Text] [Related]
8. EGFR expression variance in paired colorectal cancer primary and metastatic tumors.
Yarom N; Marginean C; Moyana T; Gorn-Hondermann I; Birnboim HC; Marginean H; Auer RC; Vickers M; Asmis TR; Maroun J; Jonker D
Cancer Biol Ther; 2010 Sep; 10(5):416-21. PubMed ID: 20595818
[TBL] [Abstract][Full Text] [Related]
9. [Immunohistochemical study on the expression of epidermal growth factor receptor (EGFR) in human colorectal carcinomas].
Takemura K; Obara T; Okano S; Yokota K; Ura H; Saitoh Y; Koike Y; Okamura K; Namiki M
Nihon Shokakibyo Gakkai Zasshi; 1991 May; 88(5):1177-83. PubMed ID: 1880949
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathologic significance of EGFR and Her-2/neu in colorectal adenocarcinomas.
Kountourakis P; Pavlakis K; Psyrri A; Rontogianni D; Xiros N; Patsouris E; Pectasides D; Economopoulos T
Cancer J; 2006; 12(3):229-36. PubMed ID: 16803682
[TBL] [Abstract][Full Text] [Related]
11. Combined application of anti-VEGF and anti-EGFR attenuates the growth and angiogenesis of colorectal cancer mainly through suppressing AKT and ERK signaling in mice model.
Ding C; Li L; Yang T; Fan X; Wu G
BMC Cancer; 2016 Oct; 16(1):791. PubMed ID: 27729020
[TBL] [Abstract][Full Text] [Related]
12. Expression of Epidermal Growth Factor Receptor in Colorectal Adenocarcinoma and its Correlation with Clinicopathological Factors.
Nemanqani DM; Aftab K; Al-Malki SH; Al-Sufyani WM
J Coll Physicians Surg Pak; 2018 Jul; 28(7):527-531. PubMed ID: 29950257
[TBL] [Abstract][Full Text] [Related]
13. Human epidermal growth factor receptor-2 family in colorectal adenocarcinoma: correlation with survival and clinicopathological findings.
Molaei M; Pejhan S; Nayer BN; Moradi A; Ghiasi S; Zali MR
Eur J Gastroenterol Hepatol; 2009 Mar; 21(3):289-93. PubMed ID: 19279475
[TBL] [Abstract][Full Text] [Related]
14. In depth evaluation of the prognostic and predictive utility of PTEN immunohistochemistry in colorectal carcinomas: performance of three antibodies with emphasis on intracellular and intratumoral heterogeneity.
Ágoston EI; Micsik T; Ács B; Fekete K; Hahn O; Baranyai Z; Dede K; Bodoky G; Bursics A; Kulka J; Krenács T; Győrffy B; Harsányi L; Szász AM
Diagn Pathol; 2016 Jul; 11(1):61. PubMed ID: 27392434
[TBL] [Abstract][Full Text] [Related]
15. P53 and EGFR expression in colorectal cancer: a reappraisal of 'old' tissue markers in patients with long follow-up.
Theodoropoulos GE; Karafoka E; Papailiou JG; Stamopoulos P; Zambirinis CP; Bramis K; Panoussopoulos SG; Leandros E; Bramis J
Anticancer Res; 2009 Feb; 29(2):785-91. PubMed ID: 19331236
[TBL] [Abstract][Full Text] [Related]
16. Impact of EGFR expression on colorectal cancer patient prognosis and survival.
Spano JP; Lagorce C; Atlan D; Milano G; Domont J; Benamouzig R; Attar A; Benichou J; Martin A; Morere JF; Raphael M; Penault-Llorca F; Breau JL; Fagard R; Khayat D; Wind P
Ann Oncol; 2005 Jan; 16(1):102-8. PubMed ID: 15598946
[TBL] [Abstract][Full Text] [Related]
17. Concurrent EGFr and Cox-2 expression in colorectal cancer: proliferation impact and tumour spreading.
Ceccarelli C; Piazzi G; Paterini P; Pantaleo MA; Taffurelli M; Santini D; Martinelli GN; Biasco G
Ann Oncol; 2005 May; 16 Suppl 4():iv74-79. PubMed ID: 15923435
[TBL] [Abstract][Full Text] [Related]
18. Significant association and synergistic adverse prognostic effect of podocalyxin-like protein and epidermal growth factor receptor expression in colorectal cancer.
Larsson AH; Lehn S; Wangefjord S; Karnevi E; Kuteeva E; Sundström M; Nodin B; Uhlén M; Eberhard J; Birgisson H; Jirström K
J Transl Med; 2016 May; 14(1):128. PubMed ID: 27160084
[TBL] [Abstract][Full Text] [Related]
19. Epidermal Growth Factor Receptor Inconsistency by Immunohistochemistry Method Using Different Monoclonal Antibodies in Colorectal Cancer Patients.
Fan CC; Wang TY; Kung CM
Clin Lab; 2015; 61(11):1635-41. PubMed ID: 26731987
[TBL] [Abstract][Full Text] [Related]
20. Epidermal growth factor receptor (EGFR) status in primary colorectal tumors correlates with EGFR expression in related metastatic sites: biological and clinical implications.
Italiano A; Saint-Paul MC; Caroli-Bosc FX; François E; Bourgeon A; Benchimol D; Gugenheim J; Michiels JF
Ann Oncol; 2005 Sep; 16(9):1503-7. PubMed ID: 15980160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
